Zhang Yiwei, Zhang Xin, Lu Hua
Department of Biochemistry & Molecular Biology and Tulane Cancer Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
Departments of Ophthalmology, Pathology & Cell Biology, Columbia University, 635 W. 165th Street, EI902A, New York, NY 10032, USA.
Dev Biol. 2014 Dec 1;396(1):19-30. doi: 10.1016/j.ydbio.2014.09.017. Epub 2014 Sep 28.
Although forming a heterodimer or heterooligomer is essential for MDM2 and MDMX to fully control p53 during early embryogenesis, deletion of either MDM2 or MDMX in specific tissues using the loxp-Cre system reveals phenotypic diversity during organ morphogenesis, which can be completely rescued by loss of p53, suggesting the spatiotemporal independence and specificity of the regulation of p53 by MDM2 and MDMX. In this study, we investigated the role of the MDM2-MDMX-p53 pathway in the developing lens that is a relatively independent region integrating cell proliferation, differentiation and apoptosis. Using the mice expressing Cre recombinase specifically in the lens epithelial cells (LECs) beginning at E9.5, we demonstrated that deletion of either MDM2 or MDMX induces apoptosis of LEC and reduces cell proliferation, resulting in lens developmental defect that finally progresses into aphakia. Specifically, the lens defect caused by MDM2 deletion was evident at E10, occurring earlier than that caused by MDMX deletion. These lens defects were completely rescued by loss of two alleles of p53, but not one allele of p53. These results demonstrate that both MDM2 and MDMX are required for monitoring p53 activity during lens development, and they may function independently or synergistically to control p53 and maintain normal lens morphogenesis.
尽管形成异二聚体或异寡聚体对于MDM2和MDMX在早期胚胎发育过程中完全控制p53至关重要,但使用loxp-Cre系统在特定组织中删除MDM2或MDMX会揭示器官形态发生过程中的表型多样性,而这种多样性可通过p53缺失完全挽救,这表明MDM2和MDMX对p53的调控具有时空独立性和特异性。在本研究中,我们研究了MDM2-MDMX-p53通路在发育中的晶状体中的作用,晶状体是一个整合细胞增殖、分化和凋亡的相对独立区域。利用从E9.5开始在晶状体上皮细胞(LEC)中特异性表达Cre重组酶的小鼠,我们证明删除MDM2或MDMX会诱导LEC凋亡并减少细胞增殖,导致晶状体发育缺陷,最终发展为无晶状体。具体而言,MDM2缺失导致的晶状体缺陷在E10时明显,比MDMX缺失导致的缺陷出现得更早。这些晶状体缺陷通过p53两个等位基因的缺失而完全挽救,但不是一个等位基因的缺失。这些结果表明,MDM2和MDMX在晶状体发育过程中监测p53活性均是必需的,它们可能独立或协同发挥作用以控制p53并维持正常的晶状体形态发生。